470 related articles for article (PubMed ID: 6779042)
21. Dose-responsive induction of mammary gland carcinomas by the intraperitoneal injection of 1-methyl-1-nitrosourea.
Thompson HJ; Adlakha H
Cancer Res; 1991 Jul; 51(13):3411-5. PubMed ID: 2054781
[TBL] [Abstract][Full Text] [Related]
22. Effect of pharmacological doses of estrogen on ovary-independent rat mammary carcinoma containing estrogen and progesterone receptors.
Yoshida H; Fukuhara T; Yamashi S; Yoshida A; Fukunishi R; Tsuji M; Matsumoto K
Cancer Res; 1983 May; 43(5):2311-6. PubMed ID: 6403234
[TBL] [Abstract][Full Text] [Related]
23. Low zinc intake suppressed N-methyl-N-nitrosourea-induced mammary tumorigenesis in Sprague-Dawley rats.
Lee S; Simpson M; Nimmo M; Xu Z
Carcinogenesis; 2004 Oct; 25(10):1879-85. PubMed ID: 15205360
[TBL] [Abstract][Full Text] [Related]
24. Induction of dorsolateral prostate adenocarcinomas and other accessory sex gland lesions in male Wistar rats by a single administration of N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2'-dimethyl-4-aminobiphenyl after sequential treatment with cyproterone acetate and testosterone propionate.
Bosland MC; Prinsen MK
Cancer Res; 1990 Feb; 50(3):691-9. PubMed ID: 2137026
[TBL] [Abstract][Full Text] [Related]
25. Human chorionic gonadotropin inhibits N-Methyl-N-nitrosourea-induced mammary carcinoma growth in female Lewis rats.
Yuri T; Lai YC; Yoshizawa K; Tsubura A
In Vivo; 2012; 26(3):361-7. PubMed ID: 22523287
[TBL] [Abstract][Full Text] [Related]
26. [Inhibition of the growth of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced mammary gland neoplasms by methionine in rats].
Anisimov VN; Miretskiĭ GI; Danetskaia EV; Troitskaia MN; Ramzaev PV
Biull Eksp Biol Med; 1981 Oct; 91(10):480-2. PubMed ID: 6797490
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Ting AY; Kimler BF; Fabian CJ; Petroff BK
Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
[TBL] [Abstract][Full Text] [Related]
28. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A
In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775
[TBL] [Abstract][Full Text] [Related]
29. Regression of rat mammary tumors associated with suppressed growth hormone.
Phares CK
Anticancer Res; 1986; 6(4):845-8. PubMed ID: 3019224
[TBL] [Abstract][Full Text] [Related]
30. Hormone dependence of 7,12-dimethylbenz[a]anthracene-induced mammary tumor growth: correlation with prostaglandin E2 content.
Foecking MK; Kibbey WE; Abou-Issa H; Matthews RH; Minton JP
J Natl Cancer Inst; 1982 Aug; 69(2):443-6. PubMed ID: 6810004
[TBL] [Abstract][Full Text] [Related]
31. Effects of sex difference, gonadectomy, and estrogen on N-methyl-N-nitrosourea induced rat thyroid tumors.
Mori M; Naito M; Watanabe H; Takeichi N; Dohi K; Ito A
Cancer Res; 1990 Dec; 50(23):7662-7. PubMed ID: 2253211
[TBL] [Abstract][Full Text] [Related]
32. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
Gandilhon P; Mélançon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
[TBL] [Abstract][Full Text] [Related]
33. Selenium inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis in the rat.
Thompson HJ; Becci PJ
J Natl Cancer Inst; 1980 Dec; 65(6):1299-301. PubMed ID: 6933274
[TBL] [Abstract][Full Text] [Related]
34. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
[TBL] [Abstract][Full Text] [Related]
35. Repeated administration of carcinogen in critical developmental periods increases susceptibility of female Wistar: han rats to mammary carcinogenesis induction.
Bojková B; Ahlers I; Kubatka P; Mociková K; Mníchová M; Ahlersová E
Neoplasma; 2000; 47(4):230-3. PubMed ID: 11043827
[TBL] [Abstract][Full Text] [Related]
36. Zinc accumulation in N-methyl-N-nitrosourea-induced rat mammary tumors is accompanied by an altered expression of ZnT-1 and metallothionein.
Lee R; Woo W; Wu B; Kummer A; Duminy H; Xu Z
Exp Biol Med (Maywood); 2003 Jun; 228(6):689-96. PubMed ID: 12773700
[TBL] [Abstract][Full Text] [Related]
37. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of mammary gland tumors by short-term treatment of estradiol-3-benzoate associated with down-regulation of estrogen receptor ERalpha and ERbeta.
Kang JS; Kim S; Che JH; Nam KT; Kim DJ; Jang DD; Yang KH
Oncol Rep; 2004 Oct; 12(4):689-93. PubMed ID: 15375486
[TBL] [Abstract][Full Text] [Related]
39. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
Bodwin JS; Clair T; Cho-Chung YS
Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
[TBL] [Abstract][Full Text] [Related]
40. Effect of retinyl acetate on the occurrence of ovarian hormone-responsive and -nonresponsive mammary cancers in the rat.
Thompson HJ; Meeker LD; Tagliaferro AR; Becci PJ
Cancer Res; 1982 Mar; 42(3):903-5. PubMed ID: 6800647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
